The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism
J. bras. nefrol; 41 (3), 2019
Abstract Introduction: Treating secondary hyperparathyroidism (SHPT), a common condition associated with death in patients with chronic kidney disease, is a challenge for nephrologists. Calcimimetics have allowed the introduction of drug therapies no longer based on phosphate binders and active vitamin ...
Fosfatasa Alcalina/sangre, Calcimiméticos/efectos adversos, Calcimiméticos/uso terapéutico, Calcio/sangre, Cinacalcet/efectos adversos, Cinacalcet/uso terapéutico, Estudios de Seguimiento, Hipercalcemia/tratamiento farmacológico, Hiperparatiroidismo Secundario/sangre, Hiperparatiroidismo Secundario/tratamiento farmacológico, Hiperfosfatemia/tratamiento farmacológico, Hipocalcemia/etiología, Fallo Renal Crónico/terapia, Hormona Paratiroidea/sangre, Fósforo/sangre, Diálisis Renal, Estudios Retrospectivos, Resultado del Tratamiento, Vitamina D/uso terapéutico